Thousands of new startups are founded every year – emerging companies with the potential to disrupt the pharma industry. To give you a head-start on emerging technologies and startups that will impact the pharma sector in 2022, we analyzed a total of 3 807 global pharma startups & scaleups. Meet 5 of the most promising startups to watch!
Global Startup Heat Map highlights 5 Pharma Startups to Watch in 2022
Out of 3 807, the 5 pharma startups to watch are chosen through the Big Data & Artificial Intelligence (AI)-powered StartUs Insights Discovery Platform, covering over 2 093 000+ startups & scaleups globally. As the world’s largest resource for data on emerging companies, the SaaS platform enables you to identify relevant startups, emerging technologies & future industry trends quickly & exhaustively.
The Global Startup Heat Map below highlights the 5 pharma startups you should watch in 2022 as well as the geo-distribution of the other 3 802 startups & scaleups we analyzed for this research. We hand-picked the 5 highlighted pharma startups based on our data-driven startup scouting approach, taking into account factors such as location, founding year, the relevance of technology, and funding, among others.
Click to download
Qubit Pharmaceuticals provides a Drug Discovery Platform
Founding Year: 2020
Location: Paris, France
Total Funding: USD 160 000
Use for: Drug Discovery, Pharmacokinetic/Pharmacodynamic Simulations
Qubit Pharmaceuticals is a French startup that develops a quantum computing-based drug discovery platform. The platform calculates the absolute free binding energy of molecules with high accuracy. The use of cloud architecture and high-performance computing (HPC) significantly improve computation speeds and, hence, simulations. This speeds up the identification of potential drug candidates. Unlike conventional models, Qubit Pharmaceuticals’ solution simulates various parameters simultaneously. As a result, the startup accelerates drug discovery while reducing the number of iterations.
pharmcon3d advances Pharmaceutical 3D Printing
Founding Year: 2020
Location: Pearland, Texas, US
Total Funding: Undisclosed
Use for: Drug 3D Printing, Personalized Medicine
US-based startup pharmcon3d provides pharmaceutical 3D printing solutions. The startup offers drug formulations optimized for 3D printing, along with dosage optimization and unique drug architecture. This allows pharmaceutical companies to create tablets of varying shapes, tailor dosages, regulate active substances, and even replace various medicines with a single capsule. The startup further provides designing and prototyping of advanced drug delivery systems which combine novel materials, manufacturing methods, and pharmaceutical science. This, along with 3D printing, enables pharma companies to speed up pre-medical assessments, print small batches of drugs, reduce wastage, and improve the consumer experience.
Novai offers Image-based Disease Identification
Founding Year: 2020
Location: Reading, UK
Total Funding: USD 1 400 000
Use for: Clinical Trials, Disease Identification
Novai is a UK-based startup that enables image-based disease identification for glaucoma, Parkinson’s disease, and multiple sclerosis, among others. The startup’s detection of apoptosis in retinal cells (DARC) technology combines genetically modified Annexin and a fluorescent dye to formulate an intravenous injection. It gathers the image of the retina and analyzes it using a patented artificial intelligence-based algorithm to detect sick, stressed, and apoptotic cells. This process enables pharma companies to track the efficacy of a drug for neurodegenerative diseases. The startup’s solution provides a translatable endpoint, improves trial findings, and saves time in drug development.
Scorpion Therapeutics facilitates Precision Oncology
Founding Year: 2020
Location: Boston, Massachusetts, US
Total Funding: USD 300 000 000
Use for: Personalized Cancer Drugs, Drug Development
US-based startup Scorpion Therapeutics advances precision oncology. The startup’s drug hunting engine integrates target identification and drug discovery solutions to accelerate drug development. To achieve this, it uses bioinformatics and affinity-based proteomics along with machine learning (ML) for rapid hit discovery, compound refinement, and lead optimization. Besides, Scorpion Therapeutics’ target-centric platform reveals non-enzymatic targets that are classified as undruggable. This approach enables the startup to identify a wide range of novel compounds and advance the modality for any given target. Contrary to the one-drug-fits-all model, the startup’s personalized cancer medicines are biomarker-driven and, hence, target only tumor tissues while reaching every cancer cell in the body.
Triomics provides a Clinical Trial Management System
Founding Year: 2020
Location: New Delhi, India
Total Funding: USD 100 000
Use for: Clinical Trial Management
Triomics is an Indian startup that develops a clinical trial management system. The startup’s online platform allows users to run biospecimen collections and monitor clinical trials remotely. The startup combines data-driven site selection and AI-based target identification along with payments and data management. The integrated solution further aids real-time monitoring, target recruitment, and inventory management while reducing operational costs. In addition, its in-house experts handle the regulatory affairs and clinical operations of the trial. Its centralized data and operation management also ensures efficient workflow as well as delivers consistent budgeting and billing. This allows sponsors to effectively manage their studies and obtain real-time information on each case.
Discover All Emerging Pharma Startups
The pharma startups showcased in this report are only a small sample of all startups we identified through our data-driven startup scouting approach. Download our free Pharma Innovation Report for a broad overview of the industry or get in touch for quick & exhaustive research on the latest technologies and emerging solutions that will impact your company in 2022!
